Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis
- 31 July 2007
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 187 (1-2) , 179-186
- https://doi.org/10.1016/j.jneuroim.2007.04.016
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Differential expression of monocyte CD163 in single – and dual‐asthmatic responders during allergen‐induced bronchoconstrictionClinical and Experimental Allergy, 2006
- Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*Critical Care Medicine, 2006
- Soluble CD163: An age-dependent, anti-inflammatory biomarker predicting outcome in sepsis*Critical Care Medicine, 2006
- Serum levels of soluble CD163 correlate with the inflammatory process in coeliac diseaseAlimentary Pharmacology & Therapeutics, 2006
- Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patientsClinical Microbiology & Infection, 2005
- The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosisAtherosclerosis, 2005
- Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failureThe Esophagus, 2005
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Soluble CD163: a marker molecule for monocyte/macrophage activity in diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2002
- Soluble CD163 Inhibits Phorbol Ester-Induced Lymphocyte ProliferationBiochemical and Biophysical Research Communications, 2001